share_log

Form 144 | 诺瓦瓦克斯医药(NVAX.US)高管拟出售1.39万股股份,价值约20.12万美元

Form 144 | Novavax(NVAX.US) Officer Proposes to Sell 201.19K in Common Stocks

Futu News ·  Jun 18 04:19

SEC FILLINGS DISCLOSED/ Jun 17, $Novavax (NVAX.US)$ Officer Dubovsky Filip intends to sell 13,904 shares of its common stock on Jun 17, with a total market value of approximately $201.19K.

Dubovsky Filip has reduced shareholding in $Novavax (NVAX.US)$ by 47,312 shares since May 14, 2024, with a total value of approximately $657.39K.

1718655593827022219.png

What is Form 144?

Form 144: Notice of Proposed Sale of Securities is a document issued by the Securities and Exchange Commission (SEC). Individuals such as executive officers and affiliates of a US-listed company must submit this form to the SEC when they intend to sell more than 5,000 shares or units of that company's stock, or if the sale price adds up to more than $50,000 in any three-month period. This regulation is known as Rule 144, under the Securities Act of 1933.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment